Gilead
Biopharmaceutical company developing and supplying medicines in virology, oncology and inflammation for patients worldwide
Highlights
- Hiring43 open roles
- New on EvolcAdded 2026-10-28
About Gilead
Gilead Sciences discovers, develops and delivers therapeutics for people with life-threatening diseases. Its work focuses on virology, oncology and inflammation, and the website cites more than 25 medicines offered globally and 53 clinical programs.
Its customers are patients with serious diseases and the healthcare systems that provide their treatment. The company also expands access to its medicines through partnerships, licensing programs and local collaborations.
Gilead Sciences, Inc. is headquartered in Foster City, California, and its website cites more than 17,000 employees across 40+ countries. Open roles are listed in the United Kingdom, Ireland, Germany, the Netherlands, France, Spain, Belgium and Switzerland, covering areas such as manufacturing, regulatory affairs, IT, finance, medical affairs and market access.
Product: Prescription medicines and clinical programs across virology, oncology and inflammation.
Jobs at Gilead (43)
Gilead is hiring for 43 roles, mostly in manufacturing, based in Uxbridge and Cork. One is remote.
Sr Director, ERP Technology & Operations
New on EvolcQA Specialist II
New on EvolcDirector, Content Operations - AgencyG
New on EvolcDirector, Commercial Product Strategy
New on EvolcLab Operations Specialist I (m/f/d)
New on EvolcSAP QM End-User Support Coordinator
New on Evolc
Companies hiring like Gilead
Leadership
- Daniel O’Day · Chairman and Chief Executive Officer, Gilead SciencesSource: company website
- Andrew Dickinson · Chief Financial OfficerSource: company website
- Dietmar Berger · Chief Medical OfficerSource: company website
- Johanna Mercier · Chief Commercial & Corporate Affairs OfficerSource: company website
- Jyoti Mehra · Executive Vice President, Human ResourcesSource: company website
More biotech & pharma companies
Hansa Biopharma
Develops antibody-cleaving enzyme medicines for patients with rare immune-mediated diseases and transplant desensitisationHAYA Therapeutics
Develops RNA-guided medicines that target non-coding RNAs in disease, with Eli Lilly as a collaboration partnerIambic Therapeutics
AI-enabled drug discovery and therapeutic development for patients and pharmaceutical partnersRemote-friendlyIllumina
DNA sequencing, microarray, and genomics software solutions for researchers, clinicians, and laboratoriesNew on EvolcRemote-friendlySalary transparentImmunic Therapeutics
Develops oral small-molecule therapies for patients with neurologic, inflammatory and autoimmune diseasesSalary transparentInceptive
AI foundation models that design sequence-based drug candidates such as mRNA, siRNA and ASOs for pharma partnersSalary transparent
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Cloudflare
- Google Tag Manager